Judge Allows Obviousness Defense At Bladder Drug Retrial

A Delaware federal judge has released two makers of generic bladder drugs from a stipulation that barred them from arguing patents held by rival Astellas Pharma Inc. are invalid for obviousness,...

Already a subscriber? Click here to view full article